Cytosorbents Hosts Webinar on CytoSorb Innovations in Sepsis Treatment and Awareness

Cytosorbents Hosts Global Webinar on Sepsis Treatment Innovations

Cytosorbents Corporation, a pioneer in blood purification therapies designed for critical care and cardiac surgery, prepares to host a significant global webinar titled "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" on September 10, 2025, at 11 AM EDT. This event aligns with Sepsis Awareness Month and World Sepsis Day, aimed at increasing awareness around sepsis while spotlighting the role of CytoSorb® in managing this severe and often life-threatening condition. The webinar serves as a platform for healthcare professionals to learn about innovative treatment strategies and the clinical application of CytoSorb in real-world settings.

Dr. Phillip Chan, CEO of Cytosorbents, leads the discussion, which features a distinguished panel of international experts in critical care, including Dr. Tobias Hübner from Switzerland, Prof. Zsolt Molnár from Hungary, and Dr. Kevin Pilarczyk from Germany. These experts will share their clinical experiences and best practices regarding the use of CytoSorb in treating sepsis and septic shock. The agenda focuses on elucidating how CytoSorb can work alongside antibiotics to enhance patient outcomes, an essential consideration given the rising incidence of sepsis globally. By providing a forum for sharing insights and experiences, the webinar aims to foster a deeper understanding of how blood purification can be integrated into existing treatment protocols for severe infections.

The significance of this event cannot be overstated, as sepsis remains one of the leading causes of morbidity and mortality in critically ill patients. With the potential to improve patient outcomes, CytoSorb is increasingly recognized as a vital component in the therapeutic arsenal against sepsis. This webinar not only aims to educate but also to empower healthcare professionals with practical knowledge that can be applied directly in their clinical practice. Attendees can register online, marking this webinar as a valuable opportunity to engage with frontline experts and enhance their understanding of contemporary treatment strategies for sepsis.

In addition to the webinar, Cytosorbents continues to emphasize its commitment to advancing blood purification technologies. The company actively engages with the medical community to promote awareness of sepsis and the critical role of innovative therapies like CytoSorb. As healthcare professionals seek effective solutions in critical care, initiatives like this webinar contribute significantly to the broader discourse on patient care and treatment efficacy in life-threatening conditions.